Drug Shortage Report for SANDOZ-CARBAMAZEPINE CR

Last updated on 2019-05-09 History
Report ID 83221
Drug Identification Number 02261839
Brand name SANDOZ-CARBAMAZEPINE CR
Common or Proper name CARBAMAZEPINE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 200MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-04-22
Estimated end date 2019-05-10
Actual end date 2019-05-08
Shortage status Resolved
Updated date 2019-05-09
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2019-05-09 English Compare
v4 2019-05-08 French Compare
v3 2019-05-08 English Compare
v2 2019-05-07 French Compare
v1 2019-05-07 English Compare